Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Yazer

Showing results (11-20 of 274) with videos related to

Pageof 28
Sort By:
Transfusion|December 16, 2014
Things aren't always as they seem: what the randomized trials of red blood cell transfusion tell us about adverse outcomesMark H Yazer, Darrell J Triulzi
Transfusion|February 27, 2018
O- product transfusion, inventory management, and utilization during shortage: the OPTIMUS studyNancy M Dunbar, Mark H Yazer,
Current Opinion in Hematology|September 28, 2007
Immune hemolysis following ABO-mismatched stem cell or solid organ transplantationMark H Yazer, Darrell J Triulzi
Transfusion|August 24, 2007
Detection of anti-D in D- recipients transfused with D+ red blood cellsMark H Yazer, Darrell J Triulzi
Transfusion|June 10, 2017
Safety of the use of group A plasma in trauma: the STAT studyNancy M Dunbar, Mark H Yazer,
JAMA|October 13, 2016
AABB Red Blood Cell Transfusion Guidelines: Something for Almost EveryoneMark H Yazer, Darrell J Triulzi
Transfusion|February 4, 2016
Patient blood management: where's the bottom?Jonathan H Waters, Mark H Yazer
Transfusion|February 15, 2020
Confusion surrounding trauma resuscitation and opportunities for clarificationNancy M Dunbar, Mark H Yazer
Transfusion|October 5, 2018
The use of low-titer group O whole blood for the resuscitation of civilian trauma patients in 2018Mark H Yazer, Philip C Spinella
Transfusion|September 6, 2012
Anti-D alloimmunization propensity cannot be determined without information on D antigen exposureMark H Yazer, Darrell J Triulzi
Pageof 28

Showing results (11-20 of 274) with videos related to

Sort By:
Pageof 28
Transfusion|December 16, 2014
Things aren't always as they seem: what the randomized trials of red blood cell transfusion tell us about adverse outcomesMark H Yazer, Darrell J Triulzi
Transfusion|February 27, 2018
O- product transfusion, inventory management, and utilization during shortage: the OPTIMUS studyNancy M Dunbar, Mark H Yazer,
Current Opinion in Hematology|September 28, 2007
Immune hemolysis following ABO-mismatched stem cell or solid organ transplantationMark H Yazer, Darrell J Triulzi
Transfusion|August 24, 2007
Detection of anti-D in D- recipients transfused with D+ red blood cellsMark H Yazer, Darrell J Triulzi
Transfusion|June 10, 2017
Safety of the use of group A plasma in trauma: the STAT studyNancy M Dunbar, Mark H Yazer,
JAMA|October 13, 2016
AABB Red Blood Cell Transfusion Guidelines: Something for Almost EveryoneMark H Yazer, Darrell J Triulzi
Transfusion|February 4, 2016
Patient blood management: where's the bottom?Jonathan H Waters, Mark H Yazer
Transfusion|February 15, 2020
Confusion surrounding trauma resuscitation and opportunities for clarificationNancy M Dunbar, Mark H Yazer
Transfusion|October 5, 2018
The use of low-titer group O whole blood for the resuscitation of civilian trauma patients in 2018Mark H Yazer, Philip C Spinella
Transfusion|September 6, 2012
Anti-D alloimmunization propensity cannot be determined without information on D antigen exposureMark H Yazer, Darrell J Triulzi
Pageof 28